We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOTI icon
1101
VanEck Morningstar International Moat ETF
MOTI
$73.9M
$403K 0.01%
12,000
WPM icon
1102
Wheaton Precious Metals
WPM
$49.8B
$403K 0.01%
10,708
-4,822
-31% -$210K
OCSL icon
1103
Oaktree Specialty Lending
OCSL
$1.02B
$402K 0.01%
18,992
+14,133
+291% +$299K
RRX icon
1104
Regal Rexnord
RRX
$13.7B
$400K 0.01%
+2,659
New +$381K
SABR icon
1105
Sabre
SABR
$716M
$400K 0.01%
33,770
HLT icon
1106
Hilton Worldwide
HLT
$71.7B
$399K 0.01%
3,023
-472
-14% -$59.7K
REAL icon
1107
The RealReal
REAL
$1.44B
$399K 0.01%
30,260
+16,957
+127% +$251K
THQ
1108
abrdn Healthcare Opportunities Fund
THQ
$778M
$399K 0.01%
17,611
+587
+3% +$14.1K
NWN icon
1109
Northwest Natural Holdings
NWN
$2.08B
$398K 0.01%
8,650
CDW icon
1110
CDW
CDW
$18.6B
$397K 0.01%
2,182
+452
+26% +$85.4K
WSC icon
1111
WillScot Mobile Mini Holdings
WSC
$4.38B
$395K 0.01%
12,455
-750
-6% -$21.7K
AUPH icon
1112
Aurinia Pharmaceuticals
AUPH
$1.88B
$394K 0.01%
17,800
-12,764
-42% -$203K
CORT icon
1113
Corcept Therapeutics
CORT
$12.1B
$394K 0.01%
20,000
IHE icon
1114
iShares US Pharmaceuticals ETF
IHE
$1.46B
$394K 0.01%
6,453
WIX icon
1115
WIX.com
WIX
$2.25B
$389K 0.01%
1,986
+13
+0.7% +$3.22K
MNDT
1116
DELISTED
Mandiant, Inc. Common Stock
MNDT
$389K 0.01%
21,837
-2,985
-12% -$56.6K
FFC
1117
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$777M
$387K 0.01%
17,387
CIEN icon
1118
Ciena
CIEN
$53.8B
$385K 0.01%
7,490
+1,150
+18% +$63.9K
MTD icon
1119
Mettler-Toledo International
MTD
$28.3B
$385K 0.01%
280
AMRC icon
1120
Ameresco
AMRC
$1.1B
$384K 0.01%
6,580
-3,984
-38% -$262K
BVN icon
1121
Compañía de Minas Buenaventura
BVN
$7.74B
$384K 0.01%
56,877
-54,450
-49% -$420K
ETW
1122
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.03B
$384K 0.01%
35,545
-341
-1% -$3.78K
BGX
1123
Blackstone Long-Short Credit Income Fund
BGX
$136M
$383K 0.01%
25,272
-4,596
-15% -$68.2K
ELS icon
1124
Equity Lifestyle Properties
ELS
$12.6B
$383K 0.01%
4,901
+857
+21% +$70.2K
IOVA icon
1125
Iovance Biotherapeutics
IOVA
$1.84B
$381K 0.01%
15,454
+115
+0.7% +$2.71K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.